Adial Pharmaceuticals ADIL

$ 1.01 -0.51%

Quarterly report 2024-Q3
added 11-13-2024

Adial Pharmaceuticals Balance Sheet 2011-2024 | ADIL

Annual Balance Sheet Adial Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-5.85 M	-4.4 M	-6.78 M	-3.87 M	671 K	146 K	-162 K	-	-	-	-
Long Term Debt	-	-	207 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	653 K	1.79 M	2.72 M	1.51 M	539 K	258 K	-	-	-	-	-	-	-
Total Liabilities	653 K	2.46 M	3.97 M	1.51 M	539 K	258 K	1.03 M	255 K	53.1 K	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-68.8 M	-63.7 M	-50.9 M	-31.5 M	-20.6 M	-12 M	-404 K	-9.94 M	-9.52 M	-	-	-	-
Total Assets	4.74 M	5.73 M	7.47 M	5.49 M	7.68 M	4.7 M	34.5 K	152 K	216 K	-	-	-	-
Cash and Cash Equivalents	2.83 M	4 M	6.06 M	4.4 M	6.78 M	3.87 M	18.2 K	-	-	-	-	-	-
Book Value	4.08 M	3.28 M	3.51 M	3.99 M	7.14 M	4.44 M	-998 K	-103 K	163 K	-	-	-	-
Total Shareholders Equity	4.08 M	3.28 M	3.51 M	3.99 M	7.14 M	4.44 M	-998 K	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Adial Pharmaceuticals

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	135 K	151 K	165 K	180 K	194 K	207 K	220 K	227 K	240 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	829 K	672 K	653 K	528 K	462 K	2.46 M	2.46 M	2.33 M	2.96 M	3.26 M	3.97 M	3.25 M	3.23 M	3.01 M	1.51 M	1.51 M	1.51 M	1.51 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-79.9 M	-77.7 M	-68.8 M	-66.9 M	-65.5 M	-66.6 M	-63.7 M	-60.8 M	-57.7 M	-53.9 M	-50.9 M	-45.1 M	-40.8 M	-36.4 M	-31.5 M	-31.5 M	-31.5 M	-31.5 M	-20.6 M	-20.6 M	-20.6 M	-20.6 M	-12 M	-12 M	-12 M	-12 M	-404 K	-404 K	-404 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	6.71 M	4.95 M	4.74 M	2.87 M	3.78 M	3.9 M	5.73 M	7.74 M	10.9 M	14 M	7.47 M	10.4 M	8.06 M	8.63 M	5.49 M	5.49 M	5.49 M	5.49 M	7.68 M	7.68 M	7.68 M	7.68 M	4.7 M	4.7 M	4.7 M	4.7 M	34.5 K	34.5 K	34.5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	5.2 M	3.29 M	2.83 M	316 K	1.22 M	2.31 M	4 M	5.75 M	9.16 M	12.7 M	6.06 M	7.18 M	5.21 M	5.64 M	4.4 M	4.4 M	4.4 M	4.4 M	6.78 M	6.78 M	6.78 M	6.78 M	3.87 M	3.87 M	3.87 M	3.87 M	18.2 K	18.2 K	18.2 K	-	88 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	5.88 M	4.28 M	4.08 M	2.34 M	3.32 M	1.44 M	3.28 M	5.41 M	7.96 M	10.7 M	3.51 M	7.2 M	4.83 M	5.62 M	3.99 M	3.99 M	3.99 M	3.99 M	7.68 M	7.68 M	7.68 M	7.68 M	4.7 M	4.7 M	4.7 M	4.7 M	34.5 K	34.5 K	34.5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	5.88 M	4.28 M	4.08 M	2.34 M	3.32 M	1.44 M	3.28 M	5.41 M	7.96 M	10.7 M	3.51 M	7.2 M	4.83 M	5.62 M	3.99 M	3.99 M	3.99 M	3.99 M	7.14 M	7.14 M	7.14 M	7.14 M	4.44 M	4.44 M	4.44 M	4.44 M	-998 K	-998 K	-998 K	-	-103 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency